To confirm our microarray findings, we employed real-time quantitative PCR (qPCR) to examine mRNA expression of IL1B, EGR1, and ITGB3 in these L-CTCL patients. The gene discussed is IL1B; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.